Ina Sarel | Director of QA, RA
NurExone Biologic

Ina Sarel, Director of QA, RA, NurExone Biologic

Dr. Ina Sarel is a biotechnology executive with over 20 years of experience in product development from discovery and Proof of Concept through pre-clinical and clinical stages. Ina has broad expertise in stem/progenitor cell therapy, CMC, and regulatory requirements and previously developed a stem cell research product commercialized by Lonza.
Some of Ina’s recent positions prior to joining Nurexone, include VP Product Development at Cellect Biotechnology, VP R&D at Hemostemix, and Project Manager at Proneuron Biotechnologies.
Ina holds a Ph.D. in Neuroendocrinology from Boston University, USA.

Appearances:



Day 1 - Wednesday 23 October @ 15:15

Showcase 6: ExoPTEN-First orphan designated medicinal product containing extracellular vesicles for the treatment of CNS injuries

Session led by: nurexone-biologic
last published: 13/Oct/24 14:15 GMT

back to speakers